Clinical trials for Cancer in United States

Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma

Study ID: NCT05602194

Sponsor

Children's Oncology Group

Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women

Study ID: NCT00539162

Sponsor

M.D. Anderson Cancer Center

Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)

Study ID: NCT06686394

Sponsor

Merck Sharp & Dohme LLC

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

Study ID: NCT04329494

Sponsor

City of Hope Medical Center

Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Managemet

Study ID: NCT05351294

Sponsor

Rutgers, The State University of New Jersey

Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma

Study ID: NCT04417660

Sponsor

National Cancer Institute (NCI)

Prospective Study of oncRNA Stratification of Cancer by Size and Stage

Study ID: NCT05833360

Sponsor

Exai Bio Inc.

Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts W/Chronic Myeloid Leukemia

Study ID: NCT06229860

Sponsor

University of California, Irvine

A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

Study ID: NCT06646276

Sponsor

Bristol-Myers Squibb

Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy

Study ID: NCT05646576

Sponsor

Massachusetts General Hospital